Cation-induced synthesis of new polyoxopalladates.

Seven polyoxopalladate compounds, [Pd(15)(SeO(3))(10)(µ(3)-O)(10)](10-), with Na(+) (1) and K(+) (2) as counterions, and Na(6)[M(II){Pd(12)(SeO(3))(8)(µ(4)-O)(8)}]·nH(2)O (M = Co (3), Zn (4), Ni (5), Cu (6), Mn (7); n = 7-9), have been prepared and characterized by SXRD, FT-IR, UV-vis, EA, TGA, and ESI-MS. These compounds comprise two distinct cluster configurations, {Pd(15)} and {M(II)Pd(12)}, which reveals the possibility of obtaining desired noble metal clusters with a certain nuclearity by using different cations as potential structural directing or template agents in synthesis. All compounds showed apparent absorptions in the visible light region, while 3 and 7 were found to show paramagnetic behavior typical of mononuclear Co(II) and Mn(II) complexes with zero-field splitting.

Transformation from [W6O19](2-) to [W6O22](8-) stabilized by Cu(II) complexation.

A rare [W6O22](8-) fragment has been first captured in aqueous solution of [W6O19](2-) by using a transition-metal complex and isolated as a new compound [Cu4(W6O22)(L1)2(H2O)2]·2H2O (1; L1 = 2-amino-4,6-bis(2-pyridyl)pyrimidine), indicating that [W6O19](2-) could also transform to [W6O22](8-) in aqueous solution besides the earlier proven ψ-metatungstates, [W10O32](4-), ß-[(H2)W12O40](6-) and [W7O24](6-).

[Synthesis and fluorescence characteristics of Eu-TB complexes with trimesic acid].

A series of mixed rare earth complexes Eu(1-x)Tb(x) (BTC) x nH2O(H3BTC=1,3,5-H3BTC, x = 0.1, 0.3, 0.5, 0.7, 0.9, 1.0) were synthesized by the reaction of trivalent rare earth chlorides with trimesic acid. The contents of rare earth were mearsured by using EDTA titration method, the element analyses of C and H were performed by Vario EL elemental analyzer. Their infrared spectra were recorded by FTIR-8900 infrared spectrophotometer with KBr pellet, and the fluorescence spectra were recorded by using a Hitachi F-4500 fluorescence spectrophotometer at room temperature. These results show that these complexes Eu(1-x) Tb(x) (BTC) x nH2O can emit intense fluorescence from europium ion, the intensity of the fluorescence of the series complexes is greater in (5)D0-->7F(1,2), and both the positions ((5)D0-->7F(1,2)) show splitting emission peaks, but the peak positions of their emission spectra basically remain unchanged. These may be caused by the different coordinating pattern of the carboxylate groups. Additionally, the fluorescence intensity of europium ions was sensitized by terbium ions and that of terbium ions was quenched by europium ions. in these complexes. It was attributed to efficient energy transfer from the strongly absorbing ligand to the rather poorly absorbing lanthanide ion. and from Tb3+ to Eu3+. Moreover, the fluorescence emission of terbium ions increased markedly in these complexes.

Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients.

Genetic variations in the NADPH/MPO system in chronic kidney disease (CKD) patients might lead to altered activity of these enzymes, and thus to altered risk for oxidative stress (OS) and cardiovascular disease (CVD). We evaluated the impact of 242C/T CYBA and -463G/A MPO polymorphisms on OS and CVD mortality in stage 5 CKD patients starting dialysis. Two hundred and fifty-seven patients were genotyped using Pyrosequencing. Plasmalogen [dimethylacetal (DMA) 16/C16:0] was used as OS marker. CVD was assessed from patient history and clinical symptoms. Prevalence of CVD was higher (35%) in GG patients (MPO) compared to AG (26%) and AA (0%) patients (p < 0.01). Patients with CC genotype (CYBA) had lower levels of DMA 16/C16:0 (ratio 0.071 +/- 0.003) compared to TT patients (0.089 +/- 0.006; p < 0.05). These patients also had increased CVD mortality compared to CT and TT patients (chi(2) 2.19; p < 0.05). We conclude that genetic variations in the NADPH/MPO system are associated with OS, presence of CVD and CVD-related mortality in CKD patients.